Comment on “Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States”
McQueen, R. Brett; Whittington, Melanie D.; Chapman, Rick H.; Kumar, Varun M.; Campbell, Jonathan D.
- 期刊名称PharmacoEconomics
- 作者McQueen, R. Brett; Whittington, Melanie D.; Chapman, Rick H.; Kumar, Varun M.; Campbell, Jonathan D.
- 印刷ISSN1170-7690
- 电子ISSN1179-2027
- 文件大小404.46KB
- 发表时间2019-5-2
- DOI10.1007/s40273-019-00802-8